An Era of Therapeutic Evolution and Revolution: Insights into Studies on Dupilumab, Tralokinumab, Lebrikizumab, Nemolizumab, Eblasakimab, and OX40/OX40L Agents (Rocatinlimab and Amlitelimab) in Moderate-to-Severe Atopic Dermatitis
<p id="p1">Atopic dermatitis (AD), a prevalent chronic inflammatory skin condition, presents with diverse phenotypes and endotypes. Traditional treatments have included topical corticosteroids, phototherapy, calcineurin inhibitors, and systemic immunosuppressants, the latter often necessitating freq...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1170522 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|